Feinstein Institute Researcher, North Shore-LIJ Leukemia

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Feinstein Institute Researcher, North Shore-LIJ Leukemia Expert Receives 2014 Wallace H. Coulter Award for Lifetime Achievement in Hematology

MANHASSET, N.Y., July 24, 2014 (GLOBE NEWSWIRE) -- Kanti R. Rai, MD, an internationally renowned leukemia researcher and hematologist, will be recognized for his 50-year career combining landmark clinical leukemia research, steadfast commitment to education and mentoring and exceptional patient care by the American Society of Hematology (ASH) with the Society's highest honor, the 2014 Wallace H. Coulter Award for Lifetime Achievement in Hematology, the North Shore-LIJ Health System announced today.

ASH President Linda J. Burns, MD, of the University of Minnesota, will present Dr. Rai with his award on December 7, during the 56th ASH Annual Meeting and Exposition in San Francisco.
Dr. Rai, of Great Neck, NY, is an investigator in the Peter Karches Center for Chronic Lymphocytic Leukemia (CLL) at The Feinstein Institute for Medical Research, the chief of the CLL Research and Treatment Program at the North Shore-LIJ Cancer Institute, and the Joel Finkelstein Cancer Foundation Professor of Medicine at Hofstra North Shore-LIJ School of Medicine, where he also holds the title of Professor of Molecular Medicine.

"With his unwavering commitment to hematology spanning more than five decades and his innumerable contributions to the field and to ASH, Dr. Rai exemplifies the values of the Wallace H. Coulter Award for Lifetime Achievement in Hematology," said Dr. Burns. "From the Rai staging system to his many clinical contributions, Dr. Rai is internationally synonymous with CLL, which serves as a testament to the great impact of his career on legions of colleagues, trainees, and patients."

The award is given to a "vital contributor" to the field of hematology, demonstrating lifetime achievement and leadership in research, education, and practice. The award commemorates the innovative spirit, visionary leadership, and entrepreneurship of Wallace Henry Coulter, who was an inventor most widely known for the development of the Coulter Principle – an established methodology for counting, measuring, and evaluating cells and microscopic particles suspended in fluid. Mr. Coulter's revolutionary technique provided the medical community with a new method for screening diseases through basic blood tests. The significance of Mr. Coulter's research is commemorated each year through the prestige of this award.

He is an international leader in the clinical evaluation and management of patients with CLL and his research in the field of CLL has pioneered contemporary approaches to this disease. Dr. Rai has been involved in diagnosing and treating CLL for almost 40 years and his publication of the "Rai" prognostic categorization of CLL in the journal Blood in 1975 was a landmark article still used by physicians and clinical investigators.

Dr. Rai has collaborated for years with Nicholas Chiorazzi, MD, and other CLL scientists at the Feinstein Institute. Dr. Rai and colleagues helped to establish the importance of fludarabine, now a standard-of-care treatment for CLL, and demonstrated the effectiveness of cladribine in treating hairy cell leukemia. Dr. Rai continues to pursue his interests in the study of the natural history of human leukemias and the molecular biology of CLL, as well as the study and identification of promising new agents in the treatment of CLL.

About The American Society of Hematology (ASH)

The American Society of Hematology (ASH) is the world's largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy. The official journal of ASH is Blood; the most cited peer-reviewed publication in the field, which is available weekly in print and online.

About The Feinstein Institute for Medical Research


Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research www.feinsteininstitute.org is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit www.FeinsteinInstitute.org .
 

A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=26709

Emily Ng 516-562-2670

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 279

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 305

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 269

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 164

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading

Top 5 Most Recently Viewed Articles

Flora Growth Corp Sees 6% Surge in After-Hours Performance

Updated Category News Views 87

A Surge in After-Hours Trading for Flora Growth Corp Flora Growth Corp. (NASDAQ: FLGC) recently demonstrated significant volatility by surging 5.98% to $10.55 during after-hours trading. This movement came not long after closing at $9.96, which marked an increase of 3.59% earlier that day. Insights from Recent SEC Filing Regulation A Filing In a notable move, Flora Growth...

Continue Reading
Qubs Introduces Qubitunes, A New Interactive Audio Experience

Updated Category News Views 205

Qubs Launches Qubitunes for Creative Play Qubs has unveiled an exciting new product, Qubitunes, which has already won the 'Top Toy' award in the startup category at a prestigious Toy Fair. This innovative toy is set to transform playtime for children by offering a unique platform where they can express their creativity and dive into their own audio storytelling...

Continue Reading
Asyad Group's Expert Transport of Heavy Cryogenic Tank

Updated Category News Views 126

Asyad Group's Successful Transport of Cryogenic Tank Asyad Group has recently completed a remarkable international transport operation, successfully moving a 115 metric ton pressurized cryogenic tank from Northern India to a major destination in Saudi Arabia. This endeavor highlights the Group's expertise in cross-border logistics. A Journey of Precision The transport...

Continue Reading
Famous Toastery Launches Holiday Fundraising Efforts

Updated Category News Views 134

Famous Toastery's Compassionate Campaign for Local Communities The Famous Toastery, known for its delightful breakfast and brunch offerings, is stepping up this holiday season with a noble initiative aimed at fighting hunger. This renowned franchise is collaborating with Feeding the Carolinas, encouraging guests to make donations that will significantly impact individuals...

Continue Reading
Jiayin Group's Upcoming Earnings Call Set for November 25, 2025

Updated Category News Views 190

Jiayin Group Inc. Announces Q3 2025 Financial Results Release Jiayin Group Inc. (NASDAQ: JFIN), a prominent fintech platform in China, has shared significant news that it will unveil its unaudited financial outcomes for the third quarter of 2025. This crucial announcement is set to occur before the U.S. markets open on November 25, 2025. The anticipation surrounding these...

Continue Reading